Ballas Samir K
Cardeza Foundation for Hematologic Research, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020064. doi: 10.4084/MJHID.2020.064. eCollection 2020.
Sickle pain is the hallmark of sickle cell disease (SCD). It could be acute, persistent/relapsing, chronic, or neuropathic. Although there is a general consensus that pain is a major manifestation of SCD, there is a controversy as to the types of pain and their interrelationship between acute, chronic, relapsing, persistent, etc. This report first reviews the general approach to the management of acute vaso-occlusive crisis (VOC) pain, including education, counseling, pharmacotherapy, non-pharmacotherapy, and fluid therapy. This is followed by the presentation of five patients that represent typical issues that are commonly encountered in the management of patients with SCD. These issues are: individualized treatment of pain, bilaterality of pain, use of illicit drugs, tolerance to opioids, opioid-induced hyperalgesia, and withdrawal syndrome. The clinical aspects and management of each of these issues are described. Moreover, such complications as tolerance and withdrawal may persist after discharge and may be mistaken as chronic pain rather than resolving, persistent or relapsing pain.
镰状细胞疼痛是镰状细胞病(SCD)的标志。它可能是急性、持续性/复发性、慢性或神经性的。尽管人们普遍认为疼痛是SCD的主要表现,但对于疼痛的类型及其在急性、慢性、复发性、持续性等之间的相互关系存在争议。本报告首先回顾了急性血管闭塞性危机(VOC)疼痛管理的一般方法,包括教育、咨询、药物治疗、非药物治疗和液体治疗。接下来介绍了五名患者,他们代表了SCD患者管理中常见的典型问题。这些问题包括:疼痛的个体化治疗、疼痛的双侧性、非法药物的使用、对阿片类药物的耐受性、阿片类药物诱导的痛觉过敏和戒断综合征。描述了每个问题的临床方面和管理方法。此外,诸如耐受性和戒断等并发症在出院后可能持续存在,可能被误认为是慢性疼痛而非缓解性、持续性或复发性疼痛。